Hangzhou Tigermed Consulting Co., Ltd (ADR)

General ticker "HNGZY" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $3.4B (TTM average)

Hangzhou Tigermed Consulting Co., Ltd (ADR) follows the US Stock Market performance with the rate: 44.1%.

Estimated limits based on current volatility of 0.0%: low 4.45$, high 4.45$

Factors to consider:

  • Company pays dividends (irregularly): last record date 2026-06-22, amount 0.01$ (Y0.22%)

Similar symbols

Short-term HNGZY quotes

Long-term HNGZY plot

Financial data

YTD 2024-12-31 2025-12-31
Operating Revenue CNY6,603.12MM CNY6,832.80MM
Operating Expenses CNY5,938.70MM CNY5,823.38MM
Operating Income CNY664.42MM CNY1,009.42MM
Non-Operating Income CNY0.04MM CNY-6.20MM
Interest Expense CNY141.24MM CNY90.56MM
R&D Expense CNY238.39MM CNY257.64MM
Income(Loss) CNY664.46MM CNY1,003.22MM
Taxes CNY216.63MM CNY198.16MM
Net Income(Loss)* CNY405.14MM CNY887.89MM
Stockholders Equity CNY20,670.65MM CNY20,959.51MM
Inventory CNY31.96MM CNY41.50MM
Assets CNY28,671.02MM CNY28,358.80MM
Operating Cash Flow CNY1,097.00MM CNY1,118.08MM
Capital expenditure CNY356.55MM CNY214.37MM
Investing Cash Flow CNY-4,739.12MM CNY491.56MM
Financing Cash Flow CNY-1,702.41MM CNY-1,926.69MM
Earnings Per Share** CNY0.47 CNY1.04
Ordinary share to ADR 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.